These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3316499)

  • 1. 31P nuclear magnetic resonance (NMR) spectroscopy of brain in aging and Alzheimer's disease.
    Pettegrew JW; Withers G; Panchalingam K; Post JF
    J Neural Transm Suppl; 1987; 24():261-8. PubMed ID: 3316499
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Magnetic resonance spectroscopy and its application to aging and Alzheimer's disease.
    McClure RJ; Kanfer JN; Panchalingam K; Klunk WE; Pettegrew JW
    Neuroimaging Clin N Am; 1995 Feb; 5(1):69-86. PubMed ID: 7743086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 31P nuclear magnetic resonance studies of phosphoglyceride metabolism in developing and degenerating brain: preliminary observations.
    Pettegrew JW; Kopp SJ; Minshew NJ; Glonek T; Feliksik JM; Tow JP; Cohen MM
    J Neuropathol Exp Neurol; 1987 Jul; 46(4):419-30. PubMed ID: 2955082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Liver regeneration after partial hepatectomy in the rat. Sequential events monitored by 31P-nuclear magnetic resonance spectroscopy and biochemical studies.
    Farghali H; Rilo H; Zhang W; Simplaceanu V; Gavaler JS; Ho C; van Thiel DH
    Lab Invest; 1994 Mar; 70(3):418-25. PubMed ID: 8145535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Magnetic resonance and PET studies in the early diagnosis of Alzheimer's disease.
    Mosconi L; De Santi S; Rusinek H; Convit A; de Leon MJ
    Expert Rev Neurother; 2004 Sep; 4(5):831-49. PubMed ID: 15853510
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular vulnerability in brain aging and Alzheimer's disease. Clinical correlates and molecular background.
    Giannakopoulos P; Gold G; Michel JP; Bouras C
    Ann Med Interne (Paris); 1998 Jun; 149(4):187-91. PubMed ID: 11490545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MRI and CSF studies in the early diagnosis of Alzheimer's disease.
    de Leon MJ; DeSanti S; Zinkowski R; Mehta PD; Pratico D; Segal S; Clark C; Kerkman D; DeBernardis J; Li J; Lair L; Reisberg B; Tsui W; Rusinek H
    J Intern Med; 2004 Sep; 256(3):205-23. PubMed ID: 15324364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuropathologic investigation in autopsies with special emphasis on findings in Alzheimer's disease].
    Leel-Ossy L; Kindler M; Szucs I; Schwarcz T
    Ideggyogy Sz; 2006 May; 59(5-6):164-77. PubMed ID: 16786711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Detection of phosphodiester resonances in the perfused heart from vertebrate ectotherms with nuclear magnetic resonance.
    Thébault MT; Raffin JP; Pennec JP; Pichon R
    Biochem Biophys Res Commun; 1993 Nov; 197(1):75-84. PubMed ID: 8250949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mapping local hippocampal changes in Alzheimer's disease and normal ageing with MRI at 3 Tesla.
    Frisoni GB; Ganzola R; Canu E; Rüb U; Pizzini FB; Alessandrini F; Zoccatelli G; Beltramello A; Caltagirone C; Thompson PM
    Brain; 2008 Dec; 131(Pt 12):3266-76. PubMed ID: 18988639
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneity of white matter hyperintensities in Alzheimer's disease: post-mortem quantitative MRI and neuropathology.
    Gouw AA; Seewann A; Vrenken H; van der Flier WM; Rozemuller JM; Barkhof F; Scheltens P; Geurts JJ
    Brain; 2008 Dec; 131(Pt 12):3286-98. PubMed ID: 18927145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Is aging part of Alzheimer's disease, or is Alzheimer's disease part of aging?
    Swerdlow RH
    Neurobiol Aging; 2007 Oct; 28(10):1465-80. PubMed ID: 16876913
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Age-related neuropathology, cognitive decline, and Alzheimer's disease.
    Keller JN
    Ageing Res Rev; 2006 Feb; 5(1):1-13. PubMed ID: 16084778
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Application of magnetic resonance spectroscopy in the study of brain disease].
    Pérez-Gómez M; Junqué C; Mercader JM; Berenguer J
    Rev Neurol; 2000 Jan 16-31; 30(2):155-60. PubMed ID: 10730323
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo imaging of axonal transport using MRI: aging and Alzheimer's disease.
    Minoshima S; Cross D
    Eur J Nucl Med Mol Imaging; 2008 Mar; 35 Suppl 1():S89-92. PubMed ID: 18204931
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
    Padmanabhan J; Levy M; Dickson DW; Potter H
    Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnetic resonance imaging of Alzheimer's pathology in the brains of living transgenic mice: a new tool in Alzheimer's disease research.
    Jack CR; Marjanska M; Wengenack TM; Reyes DA; Curran GL; Lin J; Preboske GM; Poduslo JF; Garwood M
    Neuroscientist; 2007 Feb; 13(1):38-48. PubMed ID: 17229974
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metabolism of phosphonium choline by rat-2 fibroblasts: effects of mitogenic stimulation studied using 31P NMR spectroscopy.
    Aiken NR; Szwergold ES; Kappler F; Stoyanova R; Kuesel AC; Shaller C; Brown TR
    Anticancer Res; 1996; 16(3B):1357-63. PubMed ID: 8694502
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 31P nuclear magnetic resonance study of the brain in Alzheimer's disease.
    Pettegrew JW; Moossy J; Withers G; McKeag D; Panchalingam K
    J Neuropathol Exp Neurol; 1988 May; 47(3):235-48. PubMed ID: 3367156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neuropathologic changes in Alzheimer's disease.
    Wenk GL
    J Clin Psychiatry; 2003; 64 Suppl 9():7-10. PubMed ID: 12934968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.